ACE2 and COVID-19: This concept is interrogated in a recent viewpoint article, which postulates that a reduced ACE2 expression profile at onset of COVID-19 results in an exaggerated inflammatory response on account of the acute additional loss of ACE2 receptors in the face of the virus (224).